Clinical trials
Phase 3 Hyperglycemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 7 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2016 | 1 |
| 2020 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi | 6 |
| Takeda | 4 |
| Baylor College of Medicine | 2 |
| Boehringer Ingelheim | 1 |
| Boston Medical Center | 1 |
| Eli Lilly and Company | 1 |
| Florida Atlantic University | 1 |
| GlaxoSmithKline | 1 |
| Indiana University | 1 |
| Johns Hopkins University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperglycemia | 25 |
| Diabetes Mellitus, Type 2 | 12 |
| Hypoglycemia | 7 |
| Diabetes Mellitus | 6 |
| Diabetes Mellitus, Type 1 | 4 |
| Glucose Intolerance | 2 |
| Leukemia | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Autoimmune Diseases | 1 |
| Burkitt Lymphoma | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.